Actively Recruiting
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Led by Western Sydney Local Health District · Updated on 2025-03-27
500
Participants Needed
1
Research Sites
287 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions
CONDITIONS
Official Title
The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have an upper gastrointestinal neoplastic lesion larger than 10 mm
- Lesion suitable for ESD if limited to mucosal and/or submucosal layer
- Lesion suitable for EFTR if limited to muscularis propria layer
- Lesion suitable for STER if limited to submucosal and/or muscularis propria layer
- Aged 18 years or older
You will not qualify if you...
- Younger than 18 years old
- Unable to give informed consent
- Pregnant or breastfeeding
- Have bleeding disorders or cannot stop blood thinners (such as clopidogrel, prasugrel, warfarin, dabigatran) around the procedure time
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Westmead Hospital
Sydney, New South Wales, Australia, 2145
Actively Recruiting
Research Team
M
Michael Bourke
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here